Lipoprotein Associated Phospholipase A2 Measurement

Known as: LPPLA2, Lipoprotein Associated Phospholipase A2 
The determination of the lipoprotein associated phospholipase A2 present in a sample.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
024620042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
AIMS Metabolic syndrome (MS) and atherosclerosis are chronic inflammatory conditions. Lipoprotein-associated phospholipase A2… (More)
  • table 1
  • table 2
Is this relevant?
2015
2015
Measurement of high sensitivity CRP (hsCRP) and lipoprotein-associated phospholipase A2 (LpPLA2) provides information on systemic… (More)
Is this relevant?
2015
2015
OBJECTIVE Lipoprotein-associated phospholipase A2 (LpPLA2) activity was associated with higher CHD risk in a meta-analysis, which… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2014
2014
OBJECTIVES Retired National Football League (NFL) players were reported to have high prevalence of cardiovascular risk factors… (More)
  • table 1
  • table 3
  • table 2
Is this relevant?
2013
2013
Diabetes mellitus (DM) and hypercholesterolemia (HC) have emerged as major risk factors for Alzheimer's disease, highlighting the… (More)
Is this relevant?
2012
2012
BACKGROUND   Lipoprotein-associated phospholipase A2 (LpPLA2) is a lipoprotein-bound enzyme involved in inflammation and… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2011
2011
BACKGROUND Lipoprotein-associated phospholipase A2 (LpPLA2) is a lipoprotein-bound enzyme involved in inflammation and… (More)
Is this relevant?
2011
2011
BACKGROUND A significant proportion of heart failure (HF) patients have preserved ejection fraction (EF). Considering that… (More)
Is this relevant?
2010
2010
Inflammation is a common feature of end-stage renal disease. Although there is evidence for hemodialysis (HD)-induced… (More)
  • table 1
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2007
2007
OBJECTIVE To study the effects of pioglitazone, a peroxisome proliferator-activated receptor-y agonist with vascular beneficial… (More)
Is this relevant?